About this Journal Submit a Manuscript Table of Contents
Gastroenterology Research and Practice
Volume 2012 (2012), Article ID 939350, 8 pages
http://dx.doi.org/10.1155/2012/939350
Research Article

The Impact of Simultaneous Liver Resection for Occult Liver Metastases of Pancreatic Adenocarcinoma

1Department of General, Visceral, and Transplantation Surgery, Charité Campus Virchow, Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
2Department of Hematology and Oncology, Charité Campus Virchow, Universitätsmedizin Berlin, 13353 Berlin, Germany

Received 5 July 2012; Accepted 4 October 2012

Academic Editor: Guido Schumacher

Copyright © 2012 F. Klein et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. E. Lim, M. W. Chien, and C. C. Earle, “Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients,” Annals of Surgery, vol. 237, no. 1, pp. 74–85, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. E. L. Bradley, “Long-term survival after pancreatoduodenectomy for ductal adenocarcinoma the emperor has no clothes?” Pancreas, vol. 37, no. 4, pp. 349–351, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. E. P. Dimagno, H. A. Reber, and M. A. Tempero, “AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma,” Gastroenterology, vol. 117, no. 6, pp. 1464–1484, 1999. View at Scopus
  4. J. P. Neoptolemos, J. A. Dunn, D. D. Stocken et al., “Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial,” The Lancet, vol. 358, no. 9293, pp. 1576–1585, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. R. D. Kim, P. S. Kundhal, I. D. McGilvray et al., “Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma,” Journal of the American College of Surgeons, vol. 202, no. 1, pp. 112–119, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Czernin and H. Schelbert, “PET/CT imaging: facts, opinions, hopes, and questions,” Journal of Nuclear Medicine, vol. 45, no. 1, supplement, pp. 1s–3s, 2004.
  7. K. D. Lillemoe, J. L. Cameron, J. M. Hardacre et al., “Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer: a prospective randomized trial,” Annals of Surgery, vol. 230, no. 3, pp. 322–330, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. J. L. Cameron, H. A. Pitt, C. J. Yeo et al., “One hundred and forty-five consecutive pancreaticoduodenectomies without mortality,” Annals of Surgery, vol. 217, no. 5, pp. 430–435, 1993. View at Scopus
  9. M. W. Büchler, M. Wagner, B. M. Schmied et al., “Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy,” Archives of Surgery, vol. 138, no. 12, pp. 1310–1314, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. R. J. Bold, C. Charnsangavej, K. R. Cleary et al., “Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis,” Journal of Gastrointestinal Surgery, vol. 3, no. 3, pp. 233–243, 1999. View at Scopus
  11. R. J. Bold, C. Charnsangavej, K. R. Cleary et al., “Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis,” Journal of Gastrointestinal Surgery, vol. 3, no. 3, pp. 233–243, 1999. View at Scopus
  12. P. Schlag, P. Hohenberger, and C. Herfarth, “Resection of liver metastases in colorectal cancer—competitive analysis of treatment results in synchronous versus metachronous metastases,” European Journal of Surgical Oncology, vol. 16, no. 4, pp. 360–365, 1990. View at Scopus
  13. M. Nikfarjam, M. Sehmbey, E. T. Kimchi et al., “Additional organ resection combined with pancreaticoduodenectomy does not increase postoperative morbidity and mortality,” Journal of Gastrointestinal Surgery, vol. 13, no. 5, pp. 915–921, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. K. D. Lillemoe, J. L. Cameron, C. J. Yeo et al., “Pancreaticoduodenectomy: does it have a role in the palliation of pancreatic cancer?” Annals of Surgery, vol. 223, no. 6, pp. 718–725, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Kuhlmann, S. De Castro, T. Van Heek et al., “Microscopically incomplete resection offers acceptable palliation in pancreatic cancer,” Surgery, vol. 139, no. 2, pp. 188–196, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Bassi, G. Butturini, E. Molinari et al., “Pancreatic fistula rate after pancreatic resection: the importance of definitions,” Digestive Surgery, vol. 21, no. 1, pp. 54–59, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. M. N. Wente, C. Bassi, C. Dervenis et al., “Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS),” Surgery, vol. 142, no. 5, pp. 761–768, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. M. N. Wente, J. A. Veit, C. Bassi et al., “Postpancreatectomy hemorrhage (PPH)-an International Study Group of Pancreatic Surgery (ISGPS) definition,” Surgery, vol. 142, no. 1, pp. 20–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Ouyang, P. Wang, Z. Meng et al., “Multimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and/or Chinese herbal medicine,” Pancreas, vol. 40, no. 1, pp. 120–125, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Verslype, E. Van Cutsem, M. Dicato et al., “The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006,” Annals of Oncology, vol. 18, supplement 7, pp. vii1–vii10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. E. L. A. Artifon, P. Sakai, J. E. M. Cunha et al., “Surgery or endoscopy for palliation of biliary obstruction due to metastatic pancreatic cancer,” American Journal of Gastroenterology, vol. 101, no. 9, pp. 2031–2037, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Fong, M. Gonen, D. Rubin et al., “Long-term survival is superior after resection for cancer in high-volume centers,” Annals of Surgery, vol. 242, no. 4, pp. 540–547, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Bachellier, E. Rosso, I. Lucescu et al., “Is the need for an arterial resection a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma? A case-matched controlled study,” Journal of Surgical Oncology, vol. 103, no. 1, pp. 75–84, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Marangoni, A. O'Sullivan, W. Faraj, N. Heaton, and M. Rela, “Pancreatectomy with synchronous vascular resection—an argument in favour,” Surgeon, vol. 10, no. 2, pp. 102–106, 2012.
  25. A. Thelen, S. Jonas, C. Benckert et al., “Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer,” International Journal of Colorectal Disease, vol. 22, no. 10, pp. 1269–1276, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. T. M. Pawlik, J. N. Vauthey, E. K. Abdalla, R. E. Pollock, L. M. Ellis, and S. A. Curley, “Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver,” Archives of Surgery, vol. 141, no. 6, pp. 537–543, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. T. M. Pawlik, D. Zorzi, E. K. Abdalla et al., “Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease,” Annals of Surgical Oncology, vol. 13, no. 5, pp. 712–720, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. T. M. Pawlik, A. L. Gleisner, T. W. Bauer et al., “Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis,” Annals of Surgical Oncology, vol. 14, no. 10, pp. 2807–2816, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Adam, L. Chiche, T. Aloia et al., “Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1452 patients and development of a prognostic model,” Annals of Surgery, vol. 244, no. 4, pp. 524–533, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Klempnauer, G. J. Ridder, P. Piso, and R. Pichlmayr, “Is liver resection in metastases of exocrine pancreatic carcinoma justified?” Chirurg, vol. 67, no. 4, pp. 366–370, 1996. View at Scopus
  31. S. V. Shrikhande, J. Kleeff, C. Reiser et al., “Pancreatic resection for M1 pancreatic ductal adenocarcinoma,” Annals of Surgical Oncology, vol. 14, no. 1, pp. 118–127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. A. L. Gleisner, L. Assumpcao, J. L. Cameron et al., “Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?” Cancer, vol. 110, no. 11, pp. 2484–2492, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Takada, H. Yasuda, H. Amano, M. Yoshida, and T. Uchida, “Simultaneous hepatic resection with pancreato-duodenectomy for metastatic pancreatic head carcinoma: does it improve survival?” Hepato-Gastroenterology, vol. 44, no. 14, pp. 567–573, 1997. View at Scopus
  34. D. Elias, D. Di Pietroantonio, B. Gachot, P. Menegon, A. Hakime, and T. De Baere, “Liver abscess after radiofrequency ablation of tumors in patients with a biliary tract procedure,” Gastroenterologie Clinique et Biologique, vol. 30, no. 6-7, pp. 823–827, 2006. View at Scopus
  35. C. Kamphues, R. Bova, D. Schricke, et al., “Postoperative complications deteriorate long-term outcome in pancreatic cancer patients,” Annals of Surgical Oncology, vol. 19, no. 3, pp. 856–863, 2012.
  36. M. Abu Hilal, M. J. W. McPhail, B. A. Zeidan, C. E. Jones, C. D. Johnson, and N. W. Pearce, “Aggressive multi-visceral pancreatic resections for locally advanced neuroendocrine tumours. Is it worth it?” Journal of the Pancreas, vol. 10, no. 3, pp. 276–279, 2009. View at Scopus
  37. M. C. De Jong, M. B. Farnell, G. Sclabas et al., “Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis,” Annals of Surgery, vol. 252, no. 1, pp. 142–148, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Dorffman, R. Eshkenazy, E. Brauner, Z. Assi, A. Ariche, and Y. Kluger, “Preoperative indicators for non-resectability of patients with carcinoma of the head of the pancreas,” HPB, vol. 12, p. 243, 2010.
  39. H. Oettle, S. Post, P. Neuhaus et al., “Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial,” Journal of the American Medical Association, vol. 297, no. 3, pp. 267–277, 2007. View at Publisher · View at Google Scholar · View at Scopus